GO:0120147 formylglycine-generating oxidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120147 formylglycine-generating oxidase activity describes the oxygen-dependent oxidation of a sulfatase cysteine residue to formylglycine, a reaction required for sulfatase catalytic activity.
• The reaction consumes O2 and a thiol reductant and produces a sulfatase 3-oxo-L-alanine, hydrogen sulfide, a disulfide and water.
• The eukaryotic enzyme uses copper as a cofactor, and copper supplementation increases formylglycine yields in cultured cells [2,7].
• Loss-of-function mutations in SUMF1, the gene encoding the human formylglycine-generating enzyme, cause multiple sulfatase deficiency [3,8].
• The non-catalytic N-terminal extension of the enzyme is required for biological activity and endoplasmic reticulum retention.
• Misfolded enzyme variants are recognized by protein disulfide isomerase as part of ER quality control.
Description
GO:0120147 formylglycine-generating oxidase activity is a molecular function that catalyzes the conversion of a sulfatase L-cysteine residue into a 3-oxo-L-alanine (formylglycine) in an oxygen-dependent reaction. This modification is essential because the resulting aldehyde group is part of the active site of sulfatases, a family of enzymes that hydrolyze sulfate esters from a wide range of substrates. Without this oxidation, sulfatases remain catalytically inactive, so the formylglycine-generating enzyme acts as a master activator of the entire sulfatase family. The reaction consumes molecular oxygen and a thiol reductant and releases hydrogen sulfide, a disulfide and water, which places this activity among cofactor-independent oxidases and oxygenases [1,4]. Researchers study GO:0120147 because it connects protein post-translational modification, copper homeostasis, endoplasmic reticulum quality control and human disease. The human enzyme, encoded by SUMF1, is a copper-dependent oxidase, and its activity can be enhanced by supplementing culture media with copper(II) [2,7]. Mutations that reduce SUMF1 stability or catalytic activity cause multiple sulfatase deficiency, a severe inherited disorder with variable clinical outcome [3,8]. In addition, the enzyme contains a non-catalytic N-terminal extension that is required for its biological activity and retention in the endoplasmic reticulum, and misfolded variants are recognized by protein disulfide isomerase during ER quality control [5,6]. These features make GO:0120147 a compact model for studying oxygen activation, metal cofactor usage, protein folding and disease mechanisms.
formylglycine-generating oxidase activity At A Glance
| GO ID | GO:0120147 |
|---|---|
| GO term | formylglycine-generating oxidase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Oxidation of a sulfatase cysteine to formylglycine, activating sulfatase enzymes |
| Reaction | A [sulfatase]-L-cysteine + O2 + 2 a thiol = a [sulfatase]-3-oxo-L-alanine + hydrogen sulfide + a disulfide + H2O |
| Cofactor | Copper |
| Subcellular context | Endoplasmic reticulum, mediated by the N-terminal extension |
| Disease link | Multiple sulfatase deficiency caused by SUMF1 mutations [3,8] |
What Is GO:0120147?
In simple terms, GO:0120147 describes the activity of an enzyme that uses oxygen to convert a cysteine residue in a sulfatase protein into a formylglycine residue. The formal definition is: catalysis of the reaction A [sulfatase]-L-cysteine + O2 + 2 a thiol = a [sulfatase]-3-oxo-L-alanine + hydrogen sulfide + a disulfide + H2O. This reaction is a monooxygenase-type oxidation that installs the catalytic aldehyde of sulfatases, and it is independent of external cofactors other than the copper ion bound by the enzyme [1,2,4].
Why Is formylglycine-generating oxidase activity Important in Cell Biology?
GO:0120147 is important because it is the only known activity that generates the formylglycine aldehyde required for sulfatase catalysis, so it controls the activity of an entire enzyme family that degrades sulfate esters. Defects in this activity cause multiple sulfatase deficiency, and the residual stability and activity of mutant enzyme variants determine disease severity [3,8]. The reaction also provides a tractable model for oxygen activation by a copper-dependent oxidase and for endoplasmic reticulum quality control of a folding-sensitive enzyme [2,5,6].
• Required for activation of all sulfatases, which regulate sulfate ester metabolism.
• Copper-dependent mechanism links this activity to metal homeostasis.
• Mutations in SUMF1 cause multiple sulfatase deficiency with variable severity [3,8].
• Enzyme stability and residual activity predict clinical outcome in patients [3,8].
• The N-terminal extension is required for biological activity and ER retention.
• Misfolded enzyme is recognized by protein disulfide isomerase during ER quality control.
• Copper supplementation increases formylglycine yields in biotechnological antibody production.
• The reaction is a cofactor-independent oxidase/oxygenase model for oxygen chemistry.
• It is a target for understanding post-translational modification in the secretory pathway [1,5].
• It enables aldehyde-tagged protein and antibody engineering.
What Happens During formylglycine-generating oxidase activity?
Substrate recognition and oxygen activation
In simple terms: The enzyme finds a cysteine in a sulfatase and uses oxygen to start modifying it.
The formylglycine-generating enzyme recognizes a conserved cysteine residue within the sulfatase active site and catalyzes its oxidation using molecular oxygen. The reaction is a monooxygenase-type oxidation, meaning that one oxygen atom from O2 is incorporated into the product, and the enzyme belongs to the family of cofactor-independent oxidases and oxygenases [1,4]. The eukaryotic enzyme uses copper as a cofactor for this chemistry.
Formation of formylglycine
In simple terms: The cysteine is converted into a formylglycine, which is the active aldehyde of the sulfatase.
The catalytic outcome is the conversion of a [sulfatase]-L-cysteine to a [sulfatase]-3-oxo-L-alanine, also known as formylglycine. This aldehyde is essential for sulfatase catalysis, and its formation is the defining event of GO:0120147. The reaction also produces hydrogen sulfide, a disulfide and water, and it consumes two thiol molecules as reductant.
Copper dependence and modulation
In simple terms: Copper helps the enzyme work, and adding copper can boost the reaction.
Copper is a cofactor of the formylglycine-generating enzyme, and the reaction is copper-dependent. Supplementing culture media with copper(II) increases formylglycine yields in cells engineered to produce aldehyde-tagged antibodies, showing that cofactor availability can limit the reaction in practice.
ER retention and quality control
In simple terms: The enzyme has a tail that keeps it in the right compartment and helps it fold correctly.
The non-catalytic N-terminal extension of the formylglycine-generating enzyme is required for its biological activity and for retention in the endoplasmic reticulum. Misfolded enzyme variants are recognized by protein disulfide isomerase as part of ER quality control, which can influence the amount of active enzyme.
Key Genes Involved in GO:0120147 formylglycine-generating oxidase activity
The genes and proteins most directly associated with GO:0120147 include the formylglycine-generating enzyme itself, its sulfatase substrates, and factors that support its folding, copper usage and quality control.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SUMF1 | Encodes the human formylglycine-generating enzyme that catalyzes GO:0120147 [3,8] | Mutations cause multiple sulfatase deficiency; model for disease severity [3,8] |
| SUMF2 | Accessory protein that interacts with formylglycine-generating enzyme and supports its function | Modifier of enzyme activity and ER retention |
| PDI | Protein disulfide isomerase recognizes misfolded formylglycine-generating enzyme during ER quality control | Determines folding efficiency and degradation of mutant enzyme |
| ARSA | Sulfatase substrate that requires formylglycine for catalytic activity | Model substrate for measuring formylglycine formation |
| ARSB | Sulfatase substrate activated by formylglycine | Disease-relevant readout of enzyme activity |
| GALNS | Sulfatase substrate activated by formylglycine | Readout in multiple sulfatase deficiency models |
| IDS | Sulfatase substrate activated by formylglycine | Biomarker of sulfatase activation |
| SGSH | Sulfatase substrate activated by formylglycine | Readout of enzyme function in patient cells |
| NAGLU | Sulfatase-related enzyme used as a control in sulfatase studies | Specificity control for formylglycine-dependent activation |
| SUMF1 orthologs | Conserved formylglycine-generating enzymes across eukaryotes | Comparative studies of monooxygenase mechanism |
| Copper chaperones | Deliver copper to the enzyme | Modulate cofactor availability and activity |
| Thiol reductants | Provide reducing equivalents for the reaction | Biochemical requirement for in vitro assays |
| ER oxidoreductases | Support oxidative folding of the enzyme | Quality control and stability studies |
| Antibody Fc fusion proteins | Engineered substrates for aldehyde tagging | Biotechnological application of formylglycine formation |
| SUMF1 mutant variants | Disease-associated alleles with reduced stability or activity [3,8] | Genotype-phenotype correlation studies [3,8] |
How Is formylglycine-generating oxidase activity Regulated?
The activity of the formylglycine-generating enzyme is regulated at several levels. Copper availability acts as a cofactor-dependent control point, and copper supplementation increases formylglycine yields in cultured cells [2,7]. The non-catalytic N-terminal extension is required for biological activity and endoplasmic reticulum retention, so changes in this region affect the amount of active enzyme. Misfolded enzyme variants are recognized by protein disulfide isomerase as part of ER quality control, which can target them for degradation and thereby reduce activity. In addition, the stability and residual activity of mutant enzyme variants determine disease severity in multiple sulfatase deficiency, indicating that protein folding and turnover are key regulatory determinants [3,8].
formylglycine-generating oxidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SUMF1 | Multiple sulfatase deficiency [3,8] | Patient-derived fibroblasts or CRISPR knock-in of patient mutations [3,8] |
| SUMF1 | ER quality control and misfolding | Knockout or point-mutation cell lines with PDI readouts |
| SUMF1 | Copper-dependent activity | Overexpression with copper supplementation [2,7] |
| ARSA | Sulfatase activation defect | Sulfatase activity assay in SUMF1-modified cells |
| PDI | Protein folding disease | Knockout or knockdown of PDI in reporter cells |
Multiple sulfatase deficiency
Mutations in SUMF1 that affect the stability and activity of the formylglycine-generating enzyme cause multiple sulfatase deficiency, an inherited disorder in which sulfatases are not activated [3,8]. Molecular analysis of SUMF1 mutations has shown that the stability and residual activity of mutant enzyme determine disease severity, providing a genotype-phenotype link for this activity [3,8].
Endoplasmic reticulum quality control and protein folding disease
Misfolded formylglycine-generating enzyme variants are recognized by protein disulfide isomerase during ER quality control, which can reduce the amount of active enzyme and contribute to disease. The non-catalytic N-terminal extension is also required for biological activity and ER retention, so defects in this region can impair enzyme function.
Biotechnological and therapeutic relevance
The formylglycine-generating reaction is used to produce aldehyde-tagged antibodies, and copper supplementation increases formylglycine yields in culture media. This application links GO:0120147 to protein engineering and therapeutic antibody production.
From formylglycine-generating oxidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SUMF1 abolish formylglycine formation? | SUMF1 knockout cell line [3,8] |
| Does a patient mutation reduce enzyme stability? | Point-mutation knock-in of the patient allele [3,8] |
| Can copper supplementation rescue activity? | Overexpression of SUMF1 with copper(II) treatment [2,7] |
| Where is the enzyme localized? | Tagged knock-in with an ER marker |
| How does misfolding affect turnover? | Knockout of PDI or ER quality control factors |
| Can formylglycine tagging be improved? | Engineered substrate knock-in in antibody-producing cells |
How to Study the formylglycine-generating oxidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Sulfatase activity assay | Formylglycine-dependent sulfatase catalysis | Functional readout of GO:0120147 |
| Oxygen consumption assay | O2 use during the oxidation reaction | Mechanistic characterization |
| Copper supplementation | Cofactor-dependent activity [2,7] | Boosting formylglycine yields |
| Immunoblotting | Enzyme stability and expression [3,8] | Mutant variant analysis [3,8] |
| Pulse-chase labeling | Folding and turnover of the enzyme | ER quality control studies |
| Co-immunoprecipitation | Interaction with PDI or SUMF2 [5,6] | Identification of regulatory partners [5,6] |
| Fluorescence microscopy | ER localization of tagged enzyme | Subcellular localization studies |
| Mass spectrometry | Formylglycine modification on substrates | Direct detection of the modification |
Biochemical activity assays
The reaction can be measured by detecting formylglycine formation on a sulfatase substrate or by monitoring oxygen consumption and product release. These assays define the catalytic activity of GO:0120147 and can be used with purified enzyme or cell lysates.
Copper supplementation and metal analysis
Because copper is a cofactor, activity assays can be combined with copper supplementation or metal chelation to test cofactor dependence [2,7]. Copper(II) supplementation of culture media increases formylglycine yields, providing a simple readout of cofactor availability.
Protein folding and ER quality control assays
The stability and folding of the enzyme can be assessed by pulse-chase labeling, immunoblotting and interaction studies with protein disulfide isomerase. The N-terminal extension can be deleted or mutated to test its role in ER retention and biological activity.
Disease variant analysis
Patient-derived SUMF1 mutations can be introduced into cell lines and tested for enzyme stability and residual activity to predict clinical outcome [3,8]. These experiments link specific alleles to the biochemical activity defined by GO:0120147 [3,8].
How CRISPR Can Be Used to Study GO:0120147 formylglycine-generating oxidase activity
Knockout
CRISPR knockout of SUMF1 can eliminate formylglycine-generating oxidase activity and produce a sulfatase-inactive cellular model [3,8]. Such models are useful for testing whether a candidate gene or treatment restores sulfatase activation [3,8].
Point Mutation
Point-mutation knock-in of disease-associated SUMF1 alleles allows researchers to measure the stability and residual activity of specific mutant enzymes [3,8]. This approach directly connects genotype to the biochemical activity of GO:0120147 [3,8].
Knock-in
Knock-in of epitope or fluorescent tags into SUMF1 enables localization and interaction studies while preserving endogenous regulation. Tagged knock-in lines can be used to follow ER retention and quality control [5,6].
Overexpression
Overexpression of SUMF1 or its substrates can increase formylglycine formation and is useful for producing aldehyde-tagged proteins. Overexpression combined with copper supplementation can further boost yields.
How EDITGENE Supports formylglycine-generating oxidase activity Research
Researchers studying formylglycine-generating oxidase activity-related genes often need to determine whether a candidate gene is causally involved in sulfatase activation, protein folding or disease severity. EDITGENE provides CRISPR-based cell models and screening services that let teams move from correlation to causation using the exact assays described above.
Contact EDITGENE today to design your custom CRISPR model for formylglycine-generating oxidase activity research.
Frequently Asked Questions About formylglycine-generating oxidase activity
What is formylglycine-generating oxidase activity?
It is the molecular function defined by GO:0120147 that uses oxygen to convert a sulfatase cysteine residue into formylglycine, activating the sulfatase enzyme.
What reaction does GO:0120147 catalyze?
It catalyzes A [sulfatase]-L-cysteine + O2 + 2 a thiol = a [sulfatase]-3-oxo-L-alanine + hydrogen sulfide + a disulfide + H2O.
What genes are involved in formylglycine-generating oxidase activity?
The main gene is SUMF1, which encodes the human formylglycine-generating enzyme, along with sulfatase substrate genes such as ARSA and ARSB [1,3,8].
Is copper required for formylglycine-generating oxidase activity?
Yes, copper is a cofactor of the formylglycine-generating enzyme, and copper supplementation can increase formylglycine yields [2,7].
What diseases are linked to GO:0120147?
Mutations in SUMF1 cause multiple sulfatase deficiency, and the stability and residual activity of mutant enzyme determine disease severity [3,8].
Where does formylglycine-generating oxidase activity occur in the cell?
The enzyme is retained in the endoplasmic reticulum through its non-catalytic N-terminal extension.
How is the enzyme quality-controlled?
Misfolded formylglycine-generating enzyme is recognized by protein disulfide isomerase as part of ER quality control.
Can formylglycine-generating oxidase activity be used in biotechnology?
Yes, it is used to generate aldehyde-tagged antibodies, and copper supplementation improves formylglycine yields in culture.
What is the role of the N-terminal extension?
The non-catalytic N-terminal extension is required for biological activity and retention of the enzyme in the endoplasmic reticulum.
How can researchers study GO:0120147?
They can use sulfatase activity assays, oxygen consumption assays, copper supplementation, immunoblotting and CRISPR knockout or knock-in models [1,2,3,7,8].
Conclusion
GO:0120147 formylglycine-generating oxidase activity is a copper-dependent, oxygen-using modification that installs the catalytic formylglycine of sulfatases [1,2]. Its central role in sulfatase activation explains why SUMF1 mutations cause multiple sulfatase deficiency and why enzyme stability and residual activity predict clinical outcome [3,8]. The activity is also shaped by ER retention signals and quality control factors, making it a compact model for protein folding and oxygen chemistry [5,6]. With CRISPR models and biochemical assays, researchers can dissect the mechanism and translate it into diagnostics and biotechnological applications.
References
- 1. Peng J et al.. 2015. Eukaryotic formylglycine-generating enzyme catalyses a monooxygenase type of reaction.. FEBS J 282(17):3262-74 PMID: 26077311
- 2. Knop M et al.. 2017. Copper is a Cofactor of the Formylglycine-Generating Enzyme.. Chembiochem 18(2):161-165 PMID: 27862795
- 3. Schlotawa L et al.. 2011. SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.. Eur J Hum Genet 19(3):253-61 PMID: 21224894
- 4. Fetzner S et al.. 2010. Cofactor-independent oxidases and oxygenases.. Appl Microbiol Biotechnol 86(3):791-804 PMID: 20157809
- 5. Mariappan M et al.. 2008. The non-catalytic N-terminal extension of formylglycine-generating enzyme is required for its biological activity and retention in the endoplasmic reticulum.. J Biol Chem 283(17):11556-64 PMID: 18305113
- 6. Schlotawa L et al.. 2018. Recognition and ER Quality Control of Misfolded Formylglycine-Generating Enzyme by Protein Disulfide Isomerase.. Cell Rep 24(1):27-37.e4 PMID: 29972788
- 7. York D et al.. 2016. Generating aldehyde-tagged antibodies with high titers and high formylglycine yields by supplementing culture media with copper(II).. BMC Biotechnol 16:23 PMID: 26911368
- 8. Schlotawa L et al.. 2008. Molecular analysis of SUMF1 mutations: stability and residual activity of mutant formylglycine-generating enzyme determine disease severity in multiple sulfatase deficiency.. Hum Mutat 29(1):205 PMID: 18157819
